Fig. 1: Probability of survival by hepatitis C virus (HCV) serostatus among HIV-infected subjects initiating their first antiretroviral therapy, showing deaths from natural causes only (excluding, for example, drug-overdose and traffic fatalities, suicides and homicides). The graph on the right includes data from only those subjects who were at least 95% adherent to their therapy regimen.